#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma refractory Acute on chronic liver failure IgA nephropathy Nephrotic syndrome Herpes simplex Non-small cell lung cancer metastatic Hyperchylomicronaemia Small cell lung cancer recurrent Stevens-Johnson syndrome High-grade B-cell lymphoma Gaucher's disease type I Neuroblastoma Congenital growth hormone deficiency Osteomyelitis Neuroendocrine carcinoma More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets Mucopolysaccharidosis II – Trials in Disease Angelman’s syndrome – Treatment Castleman’s disease – Treatment Encephalitis autoimmune Pelizaeus-Merzbacher disease – Life with Disease Advanced systemic mastocytosis Hypereosinophilic syndrome – Trials in Disease Hypereosinophilic syndrome – Treatment Glycogen storage disease type II – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lovotibeglogene Autotemcel Octreotide Hydrochloride Xenon XMAB942 Avalglucosidase Alfa Censavudine Blu-222 Mometasone Furoate Ph. Eur. AP31969 SULFATE Rly-4008 Benzathine Benzylpenicillin CEFTAROLINE FOSAMIL Amikacin Fluticasone Furoate FERUMOXTRAN-10 A3907 Neridronate Sodium Gad20-209-Fsp-A2 Orlistat Egl-001 More therapies…

    Learn about Your Condition

    Pustular psoriasis Hepatic cirrhosis Hypotonia Systemic mastocytosis Ovarian granulosa cell tumour Toxicity to various agents Nervous system disorder Acoustic neuroma Cryoglobulinaemia Biotinidase deficiency Retinoblastoma Neuroendocrine tumour Crohn's disease Thymoma BK virus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal and Neural Physiological Phenomena

  • Study comparing Dry Needling and Botulinum Toxin Type A treatments for leg muscle stiffness in stroke patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A
    Belgium Spain

  • Effect of High‑Dose Thiamine Hydrochloride on Fatigue in Rheumatoid Arthritis Patients: Randomized, Double‑Blind, Placebo‑Controlled Trial

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Thiamine Hydrochloride
    Denmark

  • A study to compare how the body absorbs celecoxib oral suspension and celecoxib capsules in healthy adults for the treatment of acute pain.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Dysmenorrhoea
    • Pain
    Investigated Drugs:
    • Heparin Sodium
    • Celecoxib
    Czechia

  • Study on the Impact of LF111 and Drospirenone on Bone Health in Adolescent and Adult Women Using Oral Contraceptives

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • DROSPIRENONE
    Czechia Poland

  • Study on the Expression of the 5-HT4 Receptor in Patients with Mild to Moderate Parkinson’s Disease Using [C11]-SB207145

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • (1-(111C)METHYLPIPERIDIN-4-YL)METHYL 5-AMINO-6-CHLORO-1,4-BENZODIOXINE-8-CARBOXYLATE
    France

  • Study on Treating Osteogenesis Imperfecta in Patients Using Teriparatide and Zoledronic Acid

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • ALENDRONATE SODIUM TRIHYDRATE
    • Clodronate Disodium
    • IBANDRONIC ACID
    Denmark France Ireland The Netherlands
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!